Molecular targeting of hepatocyte growth factor by an antagonist, NK4, in the treatment of rheumatoid arthritis. 2013/07
3.
原著
FK506 induces endothelial dysfunction through attenuation of Akt and ERK1/2 independently of calcineurin inhibition and the caspase pathway. 2013/09
4.
原著
Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma. 2013/11
5.
原著
Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus. 2013/12
6.
原著
Oncolytic virotherapy for osteosarcoma using midkine promoter-regulated adenoviruses. 2014/02
7.
原著
Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1. 2015/03
8.
原著
Brain vascular pericytes following ischemia have multipotential stem cell activity to differentiate into neural and vascular lineage cells. 2015/06
9.
原著
Brain vascular pericytes following ischemia have multipotential stem cell activity to differentiate into neural and vascular lineage cells. 2015/06
10.
原著
Combinatorial anti-angiogenic gene therapy in a human malignant mesothelioma model. 2015/08
11.
原著
Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams. 2016/01
12.
原著
Whole cell vaccination using immunogenic cell death by an oncolytic adenovirus is effective against a colorectal cancer model. 2016/12
13.
原著
A patient-derived xenograft and a cell line derived from it form a useful preclinical model for small bowel adenocarcinoma 2020/05
14.
原著
Assessment of circulating microRNA specific for patients with familial adenomatous polyposis 2021/05
Hybrid vectors as trojan horses; adventure with adenovirus for successful gene therapy. (口頭,特別講演・招待講演など) 2013/04/15
2.
Anti-Tumor effects of ad-p53 on INK4A/ARF-defective mesothelioma are influenced positively by small G protein inhibitors but negative by heat shock protein 90 inhibitors (ポスター掲示,一般) 2013/05/16
3.
Comparative evaluation of the antitumor activity of anti-anqioqeni proteins delivered by lentivirus vector in humaan maliqnant mesothelioma model (ポスター掲示,一般) 2013/05/16
4.
Development of dual targeted oncolytic adenovirus for human malignant mesothelioma (ポスター掲示,一般) 2013/05/18
5.
Adventure with viruses toward the success of gene therapy against malignant mesothelioma (口頭,特別講演・招待講演など) 2013/06/04
6.
遺伝性腫瘍の患者に対する患者用疾患管理ノート作成の試み (口頭,一般) 2013/06/21
7.
医学生への遺伝医学教育を通じた地域医療教育 (口頭,一般) 2013/06/22
8.
Bisphosphonates and Nutlin-3a augments cytotoxicity induced by adenovirally expressed p53 in p53 wild-type mesothelioma (口頭,一般) 2013/07/05
9.
Midkine promoter-driven oncolytic adenovirus with adenovirus 35 fiber modification achieves enhanced transduction of human osteosarcoma cells (口頭,一般) 2013/07/06
FK506 induces endothelial dysfunction through attenuation of Akt and ERK1/2 independently of calcineurin inhibition and the caspase pathway. (ポスター掲示,一般) 2013/09/27
Prodrug activator gene therapy using replicating gibbon ape leukemia virus in an experimental model of human malignant mesothelioma (口頭,一般) 2014/08/06
28.
Combination of nutlin-3a and Hsp90 inhibitors produces p53-dependent synergism on human mesothelioma cells (ポスター掲示,一般) 2014/09/25
29.
Alternative splicing of c-myc transcriptional repressor, FIR,contributes T-ALL by c-Myc activation (口頭,一般) 2014/09/26
30.
FIR splicing as a molecular sensor for bleomycin-induced DNA damage response pathway (口頭,一般) 2014/09/26
31.
Rare germline variants of transcription regulator genes in malignant mesothelioma (ポスター掲示,一般) 2014/09/27
32.
SF3B1 is a novel molecular target for induction of synthetic lethality with the other anticancer drug. (口頭,一般) 2014/09/27
33.
Suicide gene therapy by replicating gibbon ape leukemia virus in an experimental model of human malignant mesothelioma (口頭,一般) 2014/09/27
34.
Transduced p53 enhances cytotoxic effects achieved with oncolytic adenoviruses on pancreatic carcinoma cells (口頭,一般) 2014/09/27
35.
Comparative evaluation of suicide gene therapy using retroviral peplicating vectors in an experimental model of human malignant mesothelioma (ポスター掲示,一般) 2014/10/21
36.
Enhanced transduction and antitumor efficiency of fiber-modified,midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma (ポスター掲示,一般) 2014/10/21
Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors in an Experimental Model of Human Osteosarcoma (ポスター掲示,一般) 2017/05/10
56.
An Inhibitor for the MDM2-p53 Interaction Produces Synergistic Cytotoxicity with Oncolytic Adenoviruses on Mesothelioma with Wild-Type p53 Genotype (ポスター掲示,一般) 2017/05/12
57.
A MDM2 inhibitor augments cytotoxicity of oncolytic adenoviruses defective of E1B 55kDa molecules through enhancing DNA damages and apoptosis in mesothelioma (口頭,一般) 2017/07/20
A Weel kinase inhibitor increases apoptosis of replication-competent adenoviruses through induction of mitotic catastrophe and enhancement of viral replications (口頭,一般) 2017/07/22
60.
A MDM2 inhibitor achieves synergistic cytotoxicity with oncolytic adenoviruses on mesothelioma with the wild-type p53 (口頭,一般) 2017/09/30
61.
Retroviral replicating vector-mediated suicide gene therapy for osteosarcoma. (口頭,一般) 2017/09/30